Exoxemis Inc

Exoxemis is a biomedical research company based in Omaha, Nebraska, focused on the study and commercialization of Zempia®, a topical biological antiseptic system utilizing myeloperoxidase (MPO). The company has completed a placebo-controlled, randomized, international, pivotal, phase III human clinical trial with 250 subjects in each arm, providing evidence that Zempia® is safe for use in open wounds.